Loader

Pathways

PathWhiz ID Pathway Meta Data

PW128198

Pw128198 View Pathway
drug action

Chlorambucil Action Pathway

Homo sapiens
Chlorambucil is an antineoplastic agent from the nitrogen mustard alkylating class. It is indicated in the treatment of chronic lymphatic leukemia, lymphosarcoma, giant follicular lymphoma, Hodgkin's disease, non-Hodgkin's lymphoma, and Waldenström’s macroglobulinemia. This class of agents is named like that for their ability to add alkyl groups to many electronegative groups. They work by three different mechanisms all of which achieve the same result: death of the cancerous cell. The first mechanism of action is to attach alkyl groups to DNA bases. This causes the fragmentation of the DNA by repair enzymes. Secondly, the alkylating agents cause damage to DNA via the formation of cross-links. The cross-links prevent the DNA from being separated for synthesis or transcription. The third mechanism of action is the induction of mispairing of the bases, leading to many mutations.

PW144419

Pw144419 View Pathway
drug action

Chlorambucil Drug Metabolism Action Pathway

Homo sapiens

PW000706

Pw000706 View Pathway
drug action

Chloramphenicol Action Pathway

Homo sapiens
Chloramphenicol, trade names Pentamycetin and Chloromycetin, is a broad spectrum antibiotic originally derived from Streptomyces venezuelae. It inhibits protein synthesis by binding the 50S ribosomal subunit to prevent bacterial growth. Bacterial resistance has occurred through decreased uptake or permeability, ribosomal mutation and inactivation by acetylation. Adverse side effects such as aplastic anemia, bone-marrow suppression or Gray syndrome in neonates and infants have resulted in limited use. However, due to ampicillin-resistance bacterial meningitis there has been a renewed interest in the drug.

PW127416

Pw127416 View Pathway
drug action

Chloramphenicol Action Pathway - New

Homo sapiens
Chloramphenicol, trade names Pentamycetin and Chloromycetin, is a broad spectrum antibiotic originally derived from Streptomyces venezuelae . It inhibits protein synthesis by binding the 50S ribosomal subunit to prevent bacterial growth. Bacterial resistance has occurred through decreased uptake or permeability, ribosomal mutation and inactivation by acetylation. Adverse side effects such as aplastic anemia, bone-marrow suppression or Gray syndrome in neonates and infants have resulted in limited use. However, due to ampicillin-resistant bacterial meningitis, there has been a renewed interest in the drug.

PW144571

Pw144571 View Pathway
drug action

Chloramphenicol Drug Metabolism Action Pathway

Homo sapiens

PW146874

Pw146874 View Pathway
drug action

Chloramphenicol palmitate Drug Metabolism Action Pathway

Homo sapiens

PW176000

Pw176000 View Pathway
metabolic

Chloramphenicol Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Chloramphenicol are predicted with biotransformer.

PW127417

Pw127417 View Pathway
drug action

Chloramphenicol succinate Action Pathway

Homo sapiens
CS is a prodrug of chloramphenicol

PW145828

Pw145828 View Pathway
drug action

Chloramphenicol succinate Drug Metabolism Action Pathway

Homo sapiens

PW176001

Pw176001 View Pathway
metabolic

Chloramphenicol succinate Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Chloramphenicol succinate are predicted with biotransformer.